Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't make hide nor hair out of the patent you posted and scanned thru it but didn't see anything saying Brilacidin so I have no clue if Bri is a major component of the treatment, a side issue that is nice but not imperative to the cure, or just what part Bri plays in the overall functioning of this new drug.
Hope we still have the rights to Bri for use in new patents.
Will wait for B Med information as that seems to be our brightest hope at the moment.
Thanks for posting this, though, as it does show some in the medical industry recognize the important Bri could play in a number of treatments.
That was a great article you posted; thanks much
I hope that if the day ever comes when K and B may prove to be the drugs we have expected them to be that we will still be around to enjoy some of the fruits of having owned it when it started.
Wish we had someone like you directing the path for IPIX instead of a bean counter.
Was it ever given a chance to make the cut? Last I heard it did real well with renal cancer in a trial with an already approved cancer drug but then nothing, even though it was deemed totally safe from P1. Didn't even make it into P2 though a leading cancer expert, Dr. Frei, who found the cure for juvenile leukemia,said he thought Kevetrin could be useful against 50% of ALL cancers.
Wouldn't surprise me in the least to find IPIX fails and then miraculously Kevetrin ends up in some private person's hands (a BP insider most likely) that makes a fortune off it.
Friggen' Cancer Society didn't contribute one damn dollar to try and further this drug. That to me showed they have no drive to find a cure, just a steady raising of money that leads nowhere but their salaries.
So why the need to belabor this point daily? Most of us got the gist of it pretty quickly.
Medical community will never let Brilacidin out until it is owned by a BP IMO. Our only hope IMO is South America allows its use for some fungal problems (including as an eye drop to prevent blindness from fungal infections that now cause 1MM people to go blind yearly) and its effectiveness then cannot be ignored by the FDA. They didn't give a damn about it with Covid so don't see them giving it a level chance to prove its effectiveness against a bird flu outbreak.
The point I am making in this post is directly responsible IMO for IPIX and Brilacidin near death at the current time and totally on subject for this board.
So everyone is to let evil advance without any forum to chastise it?
Are you of the belief that everything regarding the COVID crisis was legit and done for the betterment of mankind? I don't
Do you believe these vaccines that came to light within months had any actual testing or scientific backing that they were safe? I don't
Do you believe Fauci was factual in anything that he did? I don't
Does Big Pharma have Congress and the FDA by the balls thru payola? I believe so
Was the closing of schools for the good of the children? I don't think so
Was the treatment of the elderly by Cuomo in NY for the good of all? I don't think so
Has Brilacidin been buried by the medical establishment to protect BP? I think so
I could go on and on but all of a sudden my view is me wearing a tin foil cap and seeing conspiracies while all these establishment folks are getting a free pass as loyal shepherds of the public?
That to me is about as crazy as saying that the SEC is concerned about the public!! SEC cares only about protecting Wall St. If it wasn't so, they would have mandated chain block trading to be able to have all trades closed daily and stop completely all illegal short sales but The Swamp and Wall St certainly aren't going to let that happen. Guess that is just another layer of tin foil I wear.
I believe Edmund Burke nailed it when he said "The only thing necessary for evil to triumph is for good men to do nothing." I believe so
Someone asked, I heard, why Leo invested in BeaMed instead of furthering Brilacidin trials.
To me the answer is obvious from previous trials, he knows the powers to be won't give B a chance in Hell to come to market unless they sell it for a mere penny on the dollar to a BP.
IMO the only way B gets on the approved list in America is if some foreign locale allows it to be used widely (as in fungal S American applications) and they can't rig the results. Run another test and the F'ing FDA will again limit the dosage and the dosings to make sure it fails. This is strictly IMO - I could be way off base but seeing how Covid Vaccines by BP got approved in weeks or a few months with NO DATA showing they were safe it would take a personal letter from God to make me change my mind.
IF B is not the drug we believe it is than all the large data computer runs and AI findings where B is in the top 2 or 3 drugs possible as a solution for a major problem are totally worthless and we are led to believe these new high tech data findings are the greatest thing in modern medicine.
To me, a person that is highly claustrophobic, losing my sight and living in my own little black world (though I know the other senses heighten to overcome the blindness) would be worse than death. Strictly my opinion.
As such, if I knew I was going blind (as do many fungal patients in S America), I would jump on anything and everything that offered any hope of me keeping my sight.
Brilacidin - has been shown to be a possible treatment (a good chance as I read it), and it has no drastically negative history in trials (if given in proper dosages), so I would jump on a treatment with it in a heartbeat. Give me a moderate dosage and if that doesn't work slowly increase until either it does start working or negative effects come about that would be life threatening (and even then I would take it for another test or two).
I may not be the norm, but I am sure there are many thousands of the million people a year that lose their sight due to fungal infection that would also be willing to try such a drug. At the very least, give 100 to 500 people a test with a hearty dose as determined to be the level to cause a positive reaction. If it proves deadly to all, sorry but thank you greatly for providing data to lower the dosage. Once you get it down to a level that works and is safe (say only 100 people per follow up trial at lower dosage) ;you may have lost less than 1000 people and yet you have saved sight for millions.
To me that is a very fair loss as they were all volunteers and I would be the first to sign up for the initial trial. Hope the powers to be in S. America feel the same way. Don't inch up on the problem as is done in America, go in big to a small test group and then scale back immediately should issues arise. That way you don't take years (as FDA did w/ Kevetrin to find it was safe until effectiveness couldn't go any higher) but maybe only six months or so.
About time medicine started changing ways (as in AI saying if dose should be deadly or not) from the old tried and true methods (unless those on the old system were making too much money under the table to keep trials slow, cumbersome, and IMO totally bullshit in many cases).
Hope Argentina and the rest of S America allow B to be used against fungal issues and that spurs FDA to look at it for acceptance in USA.
Hey, he's a college student so he has all the answers!! LOL
Heard yesterday from a fellow investor who contacted the company that the LOI is still valid and company is still expecting it to result in a PO. Hope it starts moving a bit quicker than it has but greatly relieved to hear it is still open and has not been terminated.
I thought company executives had to have filed a standard buy or sell plan of say x amount of shares at the start of every quarter; that they are not allowed to make spot purchases and sales throughout the quarter as that would be a case of insider trading.
Path doesn't mean sh** - we are talking about it being a 'me too' product and that is totally bogus no matter how 'elite' is your so called knowledge
Got a kick out of a post that classified the StingRay Laser as a me-too device. That would be like saying that the new Toyota Hydrogen powered vehicles and Tesla Electric vehicles are me-too products as well because they came after the Ford Model T.
Guess they haven't heard that a way to make money is to invent 'a better mousetrap' and that is what StingRay is doing; taking lasers to levels of perfect location and perfectly matched power never seen before and thus being 'the better mousetrap'.
I just question whether it will be fully approved this year as I thought a filing earlier had pointed to 2025 as the date of rollout and 2024 was the time to get it approved thru limited trials in various locales. If it is 2024 that would be wonderful. I am hoping it is ready for actual patient testing by June of this year.
Best wishes to you, Mack. Have to head back to work after 10 yrs of retirement. Still a believer in the science but not so much the mgt any longer. I still get pretty upset thinking how many people Brilacidin could have helped over the last decade if the medical community had gotten off their behinds.
IMO AlphaSigma has been a POS since day 1
I listened (hopped around a bit) to the first day and was ticked that I couldn't find anything re: Brilacidin.
Thanks for the update on what actually happened.
Will go back and now listen to Dr Goldman's presentation
Wouldn't one think that a drug mentioned as very safe with good test results that showed it facilitated the workings of most other drugs would be something a BP would take a shot at for a few measly millions?
IPIX has no money for P3. To date have found no partner to advance this B application so until they do B-OM sits on the sideline vegetating. IMO finding a partner is all Leo should be working on now. Until we hear something as to a partner there can be no advancement of IPIX as there is no money to do anything. and that results in no word from the company.
GMEHydro is Green Mountain Energy Co. which has been around for over 20 yrs and is 100% clean energy. They are big in the NorthEast of the country and also in Texas. ---- https://www.greenmountainenergy.com/
Had another play that looked dead to the world and yet this week they signed a deal for 2 of their units that will prove they work in a full blown industrial application and should provide for a marvelous opportunity to turn many desert areas of the world into arable living centers. The future should now be extremely bright for them as getting funding for the original units was the only thing holding them back. They did all this without having to destroy the current stockholders. So miracles do happen and it could work with IPIX just as well. Only thing holding us back is a deal and Leo knows he can't play as if he holds all the high cards in setting something up for the Oral Mucositis P3 so maybe we see some progress on that front early next year. There is always hope. We just have to stay alive until BeaMed ready to help our financial situation out but that may be a couple of years out.
I was unaware until just recently that GWTI also redesigned the Fischer-T machine (very old and established technology) used as the back end of the GWTI process w/ the G-reformer to adapt it strictly for the G-reformer. Have fingers crossed that the 2 G-reformers are ready to go sometime in Q1/Q2 '24 but completely in the dark into how long it will take to manufacture them. Wonder if they would send up the one G- reformer I think GWTI has to get the testing going and then send up the 2nd reformer when it becomes available. I am giving GWTI a couple of years to get things really going and maybe some stock appreciation but anything within 5 years will be most appreciated.
It amazes me how UTA has been able to come up with catalysts to turn syngas into fuel (diesel or jet), chemicals, hydrogen, I believe methane was mentioned (note this could be used by all major city dumps and there is next to unlimited methane gas in the ocean), and who knows how many other possibilities. As for the current G-reformers going to an electric power plant to turn into hydrogen, what happens to the balance of the syngas left after the hydrogen has been stripped, does it still contain other properties that would allow other end products to be produced or could it be processed simply to produce the vast amounts of water (I don't believe this is possible because water is simply H2O and they are stripping out the H but one never knows).
This technology does have world altering value IMO and that is why a measly $15MM or so holding up the initial prototype test was so damn frustrating. Once the hydrogen application shows to work exactly as planned (and there is absolutely NO reason it shouldn't) IMO there should be many suitors lined up at GWTI's door asking to have the same type of deal (with a nice buy in of company stock) for the oil and gas industry with the ability to change the arid lands of the world into arable lands.
For all his blustering but which IMO may be just plain BS, who should have jumped on this with both feet to advance clean energy and improved world living conditions is Bill Gates but IMO BG is simply looking out for BG.
I consider this electric company situation as a white knight saving the company for us initial investors. No other way I saw that would not entail the new investors completely wiping out current stockholders. I hope this new development saves the company and allows us current investors a chance to make a nice return on our investment. I am not looking for pie in the sky numbers (though they are not out of the question IMO) as even $1 to $2 would allow me to live my dreams.
/Does the hydrogen process only need the G-reformer as the natural gas will already be on site for conversion to hydrogen? As such, does it need the mini--refinery looking setup that GWTI has at their property near Houston?
Deos the natural gas to fuel or chemical process require the mini-refinery setup?
From what I understand they have to first get the G-reformer accredited as to safety (though they don't work with any real high pressure or finicky technology) and then do the test runs to achieve economical production.
Hope the transition to hydrogen also produces the same amount of water and heat as the fuel and chemical processes do or would there be no need for the heat/turbine setup when being used for hydrogen?
This is a godsend if this allows GWTI to finally be able to prove to the oil/gas and the electrical power industries that it is of great benefit. Could be a world changing technology for many desert areas of the world and for many disadvantaged areas where the income, water, and electric generation (in use with a turbine) could allow them to become prosperous.
The news release sure answered a lot of the questions.
I am still somewhat surprised at going the hydrogen route
I would think many of the customers would go the chemical route as hydrogen would be hard to transport IMO but here I may be wrong.
Whatever, today's news release is sure a breath of fresh air for GWTI.
Hate to see what the current Israeli war could possibly do to the BeaMed timeline. Hope they have everything offsite as the current HQ is just south of Haifa and very near the northern border and IMO in quite a precarious position as Hezbollah seems targeting an attack on Israel from this position.
Sad to say but IMO the whole Middle East will most likely be in a state of war until I die (I am 74). Hope I am wrong on this point. Have also wondered if the 2 founders, both being ex-fighter pilots, have gone back into the IDF in some capacity as I would expect them to do.
Please expand on the hydrogen production statement. Has that now replaced the chemical products which replaced the fuel products?
I can't find anything on their website mentioning hydrogen and had no clue as to the first customer buying in info either.
Do you see any way this company stays afloat over the next couple of years and are we in a better place now than 6 months ago?
Any info will be appreciated.
IMO the only survival route for IPIX is some sort of partnership and I believe OM is the best and fastest way to go. Without a partnership they will not last long enough due to finances to bring B to commerciality and maybe not last long enough to reap any payback on the BeaMed investment. I am shaking my head even now as to these new patents - who is paying for them? We don't need them now, we need to conserve every possible dollar. Not trying to be a downer, just a realist.
This pitifully small fine is just a very minor cost to Citadel of doing business. Make billions and pay a $7MM fine - who wouldn't take that return on investment?
The Citadels of the world will never go away until the stock market goes to +0 trading - which is where ALL trades must be finalized the same day they are made so that they don't get put in the float as they do now where a few market makers just keep shuffling the short trades between themselves.
We will never see the end of highly questionable posters here that seem to have no reason to be here as they publicly state they own no shares as long as short trading is allowed thru +1 or +2 trading; just the facts of life IMO.
Menendez of NJ gets hammered for his illegal dealings w/ Egypt yet Wall St. is allowed massive theft of public funds thru SHO sales with nobody even batting an eye. Anybody actually believe that governmental individuals are not getting massively paid off to keep this Wall St bonanza going at the expense of the general public?
The major question is not IF Brilacidin is a wonderful drug, but whether management and finances will allow IPIX to get to the point when revenues start rolling in. There are many of us here that were posting the exact same messages as the last couple of extremely positive posts in 2012 and somehow the medical wizards, BP powers to be, governmental bodies, and IPIX mgt haven't been able to get Brilacidin past the 'most likely great new drug on the horizon' for viruses, bacteria, inflammatory issues, fungi, etc and look where we sit now.
I would caution all new investors to not fall in love with the stock as many of us did and we now are in extremely bad shape regarding this investment. It is not as if the stock price is going to go up overnight and there is no reason to invest more than your funds set aside for 'ultra risky' investments. If IPIX does flourish, there will be time to make a fortune off of it but I would at this stage not take all the risk until a more likely avenue to success rears its head. Heed the old Wall St adage "Pigs get slaughtered" and don't go whole hog in at this time.
Even if you have a large position now, future financial requirements could require a shakeup to the point where current investors bear the brunt of the losses.
This is in no way a knock on Brilacidin, just a warning not to get overzealous until the risks come down to extremely high because IMO they are way above that at the current time.
They aren't. The volume since the start of the year has been all a sham to try and get longs to sell IMO. That is why IMO cheering for good volume on up days is just as worthless as moaning on down days - it is all simply manipulation for at the current price levels that is only a thousand to two thousand dollars a day which is chickenfeed to the big boys wanting IPIX busted
When will this change? IMO only when a deal signed that will bring in millions to IPIX ($5MM+).
The news today said BeaMed was on track to submit for FDA approval via 501(k) track in Q2 2024. So what is the 501(k) track?
From the internet I got this definition of 501(k):
510k approval is a process to get marketing clearance for a Class II Medical Device1. The process requires finding an equivalent product (predicate device) to prove its substantial equivalence1234. Once the device is proven equivalent to an already approved equivalent, it can be legally marketed as per US FDA guidelines1245. The FDA processes 510k submissions in 30-90 days2. The purpose of a 510k submission is to provide the FDA approval with documented evidence which proves that the medical device is substantially equivalent to a predicate device2. The 510k clearance process got its name from Section 510 (k) of the Federal Food, Drug, and Cosmetic Act4. Critics of the fast-track program have found loopholes in the process, such as the fact that predicate devices from which new products are being anchored have not been carefully assessed for their safety and effectiveness since they were legally marketed even before 19764.
Two things to take away from this is that (1) the approval process usually takes 30-90 days and (2) it must prove equivalent to an already approved equivalent. I find this screwy at best for most new devices are improvements of already approved devices. The current systems cannot do what the Scorpion can do so how can they judge the safety of our device compared to an older device that doctor's wouldn't even let be used on the critical patients that will require the Scorpion?
I have to admit that I have a fear that AI is going to be able to come up with something quite like the Scorpion in no time at all if they have any access to how our device works in regards to the software and the systems allowing the interaction of the laser/MRI device/etc
Very nice progress by BeaMed but IMO still far too early to have any impact on SP as system won't even get FDA approval until summer of next year.
Hope that we get to test the system prior to that (maybe Mar//Apr?) on actual patients so that FDA can give approval by summer. Doesn't everyone agree that there are patients out there now that have such severe epileptic seizures that cannot be operated on w/ today's technology who would gladly consent to being a guinea pig for this new system if it gives them a chance at a normal life?
I had mentioned this time frame earlier this year and also that it may take another year or two after FDA approval before BeaMed determines it is the appropriate time to file an IPO. This delay would be so they could show a steep ramp up of revenues prior to IPO so IPO would bring in a nice offering price. IPIX must ensure we last that long and it is my main concern for the investment at this time.
It does appear though that the Scorpion System may become the 'standard' for laser surgical use across all areas of medicine.
IMO we still need a deal soon and it must bring in $10MM to keep IPIX fluid. Even if that means giving up a wad re: OM or some form of IBD I say take the deal so we don't go under completely.
Glad to see today's news, expected it due to the leadership at BeaMed, but still quite a ways to go IMO until we see some uptick in share price.
Am I missing something as to the VAST importance of this thesis?
For academic purposes, a thesis embargo, this important finding and working towards a possible solution has been stuck on the shelf for the last 2 years at the site of a government biolab. I am sure the sufferers of this condition and the loss of livestock incurred are applauding that this be kept secret for some damn academic purpose. Nothing like sitting on knowledge w/ your thumb up you a** to cater to academe for a few years.
Makes me think these medical investigators are all about the investigating and could give a damn about making any headway on the conditions being investigated.
I find this criminal.
This is the article I have been referring to in my posts but I thought that this embargo was not just for this condition but for the entire 20 viruses that have been under study during that time at GMU.
looks to me like the whole mgt group is getting a golden parachute as they all intend to leave come 1 Feb 24. this appears to me to be a perfect scenario where the mgt group takes care of themselves in a royal manner and screws the stockholders to the wall. would love to see this group taken to court to have to validate the monies they are being paid or else be judged to be robbing the shareholders.
Your article looks good for B and the anti-bacterial side of things and the big study of 20 viruses done over 2022 and possibly even late 2021 is due to be released sometime in Sept or Oct if I remember correctly. That should give Brilacidin a good deal of exposure on the anti-viral front but to be honest prior studies have not done that much for B and IPIX. How much did the white paper on Brilacidin that was sent to all the world's immunologists spur in the way of expedited investigation. To date looks pretty paltry.
I still am leaning towards S. America and the anti-fungal properties of Brilacidin taking the lead in bringing B to marketability. S. American as anxious as IPIX to get B to market to start generating revenues for them (they signed a deal w/ IPIX already regarding anything they bring to market using B) and they also need it to raise their legitimacy in the world of medical research per their own admission.
Your antibacterial study mentioned "Importantly, compound 30 showed potent in vivo efficacy in a murine model of bacterial keratitis
The S. America article said that B showed promise for anti-fungal keratitis which blinds over 1MM people / year.
I looked up keratitis and it is simply the inflammation (B is also a very strong anti-inflammatory) of the cornea. Some are bacterial related, some fungal, and can either be infectious or non-infectious (as due to an injury). What I found on line is that most are easily treatable but obviously some of the infectious types (bacterial, fungal) are quite severe. Hope Brilaicidin can be found as a treatment for these conditions.
I agree that Hungry Ghost made a wonderful post and I hope that one day SOON that we see something come about to change the fortunes of IPIX. One thing I think that needs to be added, though, is that in all likelihood it was Dr. Menon that identified the value of the Polymedix drugs of which Brilacidin is a part, as he was the medical phenom of IPIX (then called Cellceutix). Leo was and is strictly a financial guy and identifying new medical technology, such as all of the Polymedix library was, is not in his wheelhouse of knowledge.
I don't think new investors have any clue how much IPIX lost when Dr. Menon got hurt in an automobile accident and had to drop his work and involvement with IPIX. If he had been here all these years IPIX would not be in the troubled position it is today IMO.
Something is inherently wrong with this investment on oh so many fronts.
1. The very small lab at UTA has proven over the last number of years that the process is safe (no high pressures or unstable materials that could cause problems, etc), the catalysts work for the original gas-to-fuel process and the newer gas-to-chemical products, the system doesn't require a large footprint or outlandish power requirements to run, etc. Bottom line is the system works.
2. What has been holding the company back has been said to be not having the funds to build an initial full-sized unit that can be set up to get Enginnering/Safety certifications for the plant, show the actual volume the plant can provide, and establish the profitablility of the unit in regards to value of output compared to costs to produce the output. Last I heard it was somewhere in the range of $15MM to get this unit up and running at the Wharton facility.
3. This technology could be world changing in being able to capture stranded gas worldwide, be able to use waste gases that today have to be flared from oil drilling operations or emitted into the air such as biomass ethane gas, etc The potential value is in the hundreds of billions of dollars. Yet they can't find some large gas, chemical, energy company, country that is mostly desert and could transform a lot of their wasted useless land into productive land that could be made arable with the water generated by the plant and small towns built with the electricity that could be generated from an attached turbine to the unit, or individuals that are quite wealthy so $15MM wouldn't cause them much damage should it prove ineffective? It just doesn't add up.
4. I know the company had an offer made to them a year or two ago that I was told looked pretty promising yet it was turned down by mgt, then within the last couple of months I was told by the company that they had 3 offers they were evaluating for potential partnership of some type and these were being considered. Well, it looks so far that they are going to be turned down.
Does mgt not realize the common stockholder at this juncture would jump at anything that would provide ANY chance whatsoever that the comopany can survive? Do they think a white knight is going to appear with just the deal they want? I question mgt as IMO this is looking so much like a lost cause and they are doing nothing as the water is rising in the small safety boat.
Why still have the UTA lab running? After years they pretty much know everything as to how the process runs so no new data can be forthcoming.
To me this is like having a new hydrogen powered engine that is totally proven out but it will take $25MM to get a prototype built and the company is saying they can't find a source to come up with the $25MM in a market that is in the hundreds of billions if not trillions worldwide.
Like I have been saying, something is strongly askew and it is damn frustrating to see no movement forward in years. Even a letter to the stockholders now and then would be greatly appreciated just to let us know somebody is doing something.
Looked up the 2 names associated with the patent mentioned today in a previous post: Subhash Dhawan and Scott Medway,. Very interesting findings if I got the right people and I think I did:
Subhash Dhawan (from LinkedIn) Viral immunologist with a Ph.D. in biomedical research and more than 25 years of experience with the United States Food and Drug Administration (FDA) regulatory processes.
Viral immunologist with a Ph.D. in biomedical research and more than 25 years of experience with the United States Food and Drug Administration (FDA) regulatory processes. Served as a Principal Investigator and Chief of the Viral Immunology Section to direct and manage an independent research program involving infections: HIV-1, Ebola virus, West Nile virus, Zika virus, and mycoplasma. Actively participated in the FDA review process of 510(k), IDE, IND, and BLA submissions related to in vitro diagnostics, and conducted several US and foreign pre-approval/pre-licensure inspections of manufacturing facilities. Chaired or served as a member on several internal FDA regulatory committees, represented FDA as an ad hoc external committee member for developing guidance for diagnosis and monitoring of infectious diseases, and presented invited and keynote addresses at domestic and international conferences.
Work Experience
BIOMEDICAL SCIENTIST (INDEPENDENT) Graphic
Senior FDA Research & Regulatory Scientist (Retired)
BIOMEDICAL SCIENTIST (INDEPENDENT)
Jan 2019 - Present4 years 8 months
United States
• Independent science writer
• Invited reviewer of manuscripts for peer-reviewed scientific journals
• Can provide guidance on research and regulatory projects related to in vitro diagnostics, vaccines, and therapeutics
• Can provide short-term or long-term contractual and consulting services for advancing research and regulatory projects
• Can provide editorial assistance
Published six articles and filed a patent application (U.S. and PCT Patent Pending) after retiring (Wonder if the Patent Pending mentioned was this one for the Therapeutic Swabs????)…
FDA Graphic
Senior FDA Research & Regulatory Scientist
FDA
Apr 1993 - Dec 201825 years 9 months
United States
Senior Investigator and Chief, Viral Immunology Section, Laboratory of Molecular Virology
Laboratory Research:
• Directed a comprehensive research program to conduct investigation on HIV-1 and other viruses, including Ebola, Zika, and poxvirus. Other administrative responsibilities included planning, coordinating research with outside collaborators, management, and supervision of research fellows and students.
Product Regulation:
• Provided guidance and…
Scott Medway (following from LinkedIn)
United States Patent and Trademark Office
Feb 2008 - Present15 years 7 months
* Examining patent applications for medical devices (drug infusion pumps, catheters, angioplastics, surgical sealants, perfusion therapy, surgical methods, etc)
* Researching and analyzing prior art documents
* Communicating findings on novelty/non-obviousness and applying relevant case law
* Negotiating with patent practitioners upon the interpretation of patent language
* Passed USPTO Certification (Patent Bar Equivalency) Exam
IMO they must have seen something they really liked about Brilacidin
Since there was positive news today with the patent for Therapeutic Swabs for anti-inflammation using Brilacidin as seemingly the active ingredient in the swab (don't know how use of B via a swab wasn't already a patented use for B by IPIX) one knew that the loser cabal had to once again take the stock price down. Regular as clock work. But a patent is useless for us right now as it will take years probably to bring it to commercialization since it is being introduced into the body via the nose or throat IMO.
Why? She never brought anything to the board but outlandish BS. As fake as the loser cabal that keeps slamming IPIX constantly.